SPOC Proteomics

Website: https://spoc.bio/

SPOC Biosciences’ sensor-integrated proteome on chip (SPOC) synthesizes 192-1152 proteins (full-length, peptides, miniproteins) or antibody (VHH, scFv, Fab) drugs directly on biosensor chips (SPR, MALDI) for library-scale kinetic affinity screening supporting AI-enabled and traditional antibody discovery pipelines. SPOC KinetiKx datasets include on-rate (ka), off-rate (kd), affinity (KD), and residence time (t1/2). SPOC’s proprietary Protein NanoFactory production system utilizes cell-free expression with simultaneous capture-purification directly onto SPR chips, reducing time and cost for library-scale dataset generation compared to traditional recombinant protein workflows. SPOC HyperKinetiKx SPR Product Suite supports antibody drug discovery efforts for affinity ranking (AffiRank), affinity maturation (AffiBoost), epitope binning (EpiScope), epitope mapping (AminoMap) and polyreactivity screening (ReactiScan). SPOC HyperSynaptiKx SPR Product Suite is specifically designed to produce on-demand, large-scale, high-resolution datasets for validation and training in AI-driven drug discovery and development. HyperSynaptiKx SPR assays include lab-in-the-loop services for wet lab testing in DBTL cycles (BuildLoopIQ) and customer-defined antibody vs target library-on-library screening (ContactIQ). 

Weave Bio

Website: https://www.weave.bio/

Please visit our website for more information.

Zephyr AI

Website: https://www.zephyrai.bio/

 

Zephyr AI is a precision-medicine company unifying enterprise-scale real-world data with multi-modal AI to deliver actionable, biologically interpretable insights across the therapeutic lifecycle—from discovery to clinical deployment. Our software-native, AI-enabled modules predict drug response and reconstruct gene-expression signatures from clinically available DNA-based inputs and drug metadata, and can be fine-tuned to novel therapeutics or diagnostics. Pilots stand up in weeks, informing patient stratification, trial optimization, label expansion, and indication discovery.

Nexus, our SOC 2/HIPAA-aligned data and compute infrastructure, powers rapid cohort construction, synthetic control arms, and real-world validation with intervention-specific risk modeling. Through Aster Insights™ and the ORIEN Total Cancer Care® study, Zephyr provides access to deeply annotated oncology assets—lifetime-consented patients with linked clinical, exome, transcriptome, and whole-slide imaging—to enable fit-for-purpose data generation. We partner with biopharma, diagnostics, and digital-pathology leaders, integrating seamlessly into existing workflows with no new assays required. Together with a rigorous validation engine grounded in real-world outcomes, Zephyr bridges experimental and clinical domains to extract signal from heterogeneous data, de-risk development, and bring effective therapies to patients sooner. Our mission is to make precision medicine accessible and immediate—turning fragmented data into confident, patient-impacting decisions at scale.

Cytiva

Website: https://www.cytivalifesciences.com/about-us

Cytiva is a global life sciences leader dedicated to helping customers discover and commercialize the next generation of therapeutics. Together, we bring dedicated technical expertise and a broad portfolio of tools and technologies that enable the development, manufacture, and delivery of transformative medicines to patients. Visit cytiva.com to learn more. 

Faculty AI

Website: https://faculty.ai/

Founded in 2014, Faculty is one of Europe’s leading applied AI companies. Our suite of AI services and products helps organisations design, build, and deploy high-performing AI solutions that deliver measurable impact for their frontline teams. Faculty is also the developer of Faculty Frontier™, a Decision Intelligence platform used by leading pharmaceutical companies to transform decision-making at scale.

Widely recognised as a leader in AI safety, we work closely with the world’s top AI labs, such as OpenAI and Anthropic, to ensure their latest models are safe, human-led, and explainable. Our expertise spans advising Boards, leadership teams, and governments on AI strategy; delivering AI systems that improve critical public services and business outcomes; and equipping organisations with the knowledge and skills they need to thrive in the AI era.

Our PhD-heavy team has delivered hundreds of real-world AI projects across every sector of the economy. Headquartered in London, Faculty remains founder-led and has raised over £40m from investors including The Apax Digital Fund, LocalGlobe, and GMG Ventures.

Strangeworks

Website: https://strangeworks.com/

Strangeworks is on a mission to turn computational complexity into real world solutions. With the largest catalog of quantum and quantum-inspired computing resources on an innovative cloud platform backed by computational experts, we make the transformative potential of quantum computing accessible to all. Our AI powered workflows make it easier for enterprises to solve today’s toughest challenges, accelerate breakthroughs, and future-proof their operations. Partnering with customers worldwide, Strangeworks delivers immediate ROI while shaping a smarter, quantum-enabled future.

Helix AI

Website: https://helixai.com/

HelixAI is a specialist scientific technology company focused on accelerating research and development for biopharmaceutical organizations. Its platform, JarvisAI, enables scientific teams to design and execute in silico R&D workflows that support a wide range of operations from early-stage drug discovery to scale-up and bioproduction. By integrating scientific data from public, private and client domains along with computational models and AI-driven orchestration, JarvisAI helps researchers explore hypotheses more efficiently and prioritize the most promising drug candidates for further development. This approach supports better, faster decision-making combined with optimization of scientific and wet-lab resources.